Latest news
TALAPRO-3 Results and the Role of Upfront PARP Inhibition in APMS Prostate Cancer - Andrew Armstrong - UroTodayUroToday · Fri, 07 Aug 2026 19:52:20 GMTBioLineRx reports preclinical data on GLIX1 with PARP inhibitor - Investing.comInvesting.com · Fri, 07 Aug 2026 10:13:13 GMTFDA Sets a Late-2026 Decision on Adding a PARP Inhibitor to Hormone Therapy for Advanced Prostate Cancer - Medical DailyMedical Daily · Fri, 31 Jul 2026 15:45:45 GMTPharmanovia licenses China-approved PARP drug for up to €423.5M - European Biotechnology MagazineEuropean Biotechnology Magazine · Fri, 31 Jul 2026 13:54:45 GMTPARP Inhibitors for Prostate Cancer: 5 Things to Know - MedscapeMedscape · Thu, 30 Jul 2026 07:00:00 GMTTargeting a signaling pathway activated by acidic tumor environment restores treatment response to PARP inhibitors in ovarian cancer - UT MD AndersonUT MD Anderson · Wed, 29 Jul 2026 18:01:15 GMT